Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab′)2  Jörgen Elgqvist,

Slides:



Advertisements
Similar presentations
Preoperative Evaluations: The Very Last Chance To Identify a Problem With a Pacemaker or Implanted Cardioverter-Defibrillator Marc A. Rozner, PhD, MD Journal.
Advertisements

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.
Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review  David.
Glucose Metabolism Gene Expression Patterns and Tumor Uptake of 18F- Fluorodeoxyglucose After Radiation Treatment  George D. Wilson, PhD, Bryan J. Thibodeau,
COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results.
Correlation of 18F-FDG Avid Volumes on Pre–Radiation Therapy and Post–Radiation Therapy FDG PET Scans in Recurrent Lung Cancer  Nadya Shusharina, PhD,
Voice Quality After Treatment of Early Vocal Cord Cancer: A Randomized Trial Comparing Laser Surgery With Radiation Therapy  Leena-Maija Aaltonen, MD,
The Case for Prostate Brachytherapy in the Affordable Care Act Era
A Comparison of Soft-Tissue Implanted Markers and Bony Anatomy Alignments for Image-Guided Treatments of Head-and-Neck Cancers  Omar A. Zeidan, Ph.D.,
Toxicity of Gamma Knife Radiosurgery in the Treatment of Intracranial Tumors in Patients With Collagen Vascular Diseases or Multiple Sclerosis  Dot Lowell,
The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation.
Decline of Tumor Vascular Function as Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is Associated With Poor Responses to Radiation.
A Double-Blind Placebo-Controlled Randomized Clinical Trial With Magnesium Oxide to Reduce Intrafraction Prostate Motion for Prostate Cancer Radiotherapy 
Xiaoyan Wu, M. D. , Ph. D. , Peili Chen, M. D. , Ph. D. , Stephen T
Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer 
A Dose Escalation and Pharmacodynamic Study of Triapine and Radiation in Patients With Locally Advanced Pancreas Cancer  Ludmila Katherine Martin, MD,
18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy 
Leena Kankaanranta, M. D. , Tiina Seppälä, Ph. D. , Hanna Koivunoro, M
T. Liu, J. Zhou, S. A. Woodhouse, P. B. Schiff, P. Zhang, K. S
Comparison of Nodal Risk Formula and MR Lymphography for Predicting Lymph Node Involvement in Prostate Cancer  Willem M.L.L.G. Deserno, M.D., M.Sc., Oscar.
Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma  Q. Le, A.
Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.
Individualized Positron Emission Tomography–Based Isotoxic Accelerated Radiation Therapy Is Cost-Effective Compared With Conventional Radiation Therapy:
Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy  Afshin Rashtian, M.D., Shawn Iganej,
Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation  Rahul R. Parikh, M.D., Bruce.
Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG) 
Morten Hoyer, Ph. D. , Henrik Roed, D. M. Sc
Jerry D Slater, M. D. , Carl J Rossi, M. D. , Les T Yonemoto, M. D
A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute  Thomas J. FitzGerald,
Obituary and Tribute to John “Jack” Francis Fowler, PhD, DSc ( ) 
Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long- Term Follow-up  Bas Kreike, M.D., Augustinus A.M. Hart, M.Sc., Tony.
Frederiek M. Lever, MD, Irene M. Lips, MD, PhD, Sjoerd P. M
Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast.
Dose–Volume Relationships Associated With Temporal Lobe Radiation Necrosis After Skull Base Proton Beam Therapy  Mark W. McDonald, MD, Okechukwu R. Linton,
Lifetime Increased Cancer Risk in Mice Following Exposure to Clinical Proton Beam– Generated Neutrons  Leo E. Gerweck, PhD, Peigen Huang, MD, Hsiao-Ming.
Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials  Gustavo Arruda Viani,
Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases  Isabelle Thibault, MD, Mikki Campbell,
Effect of variations in atelectasis on tumor displacement during radiation therapy for locally advanced lung cancer  Nathan Tennyson, MD, Elisabeth Weiss,
Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma
International Journal of Radiation Oncology • Biology • Physics
Vaginal Motion and Bladder and Rectal Volumes During Pelvic Intensity-Modulated Radiation Therapy After Hysterectomy  Anuja Jhingran, M.D., Mohammad Salehpour,
Hendrik Westendorp, MSc, Tonnis T. Nuver, PhD, Carel J
Active Breathing Control in Combination With Ultrasound Imaging: A Feasibility Study of Image Guidance in Stereotactic Body Radiation Therapy of Liver.
Therapeutic Efficacy of Astatine-211–Labeled Trastuzumab on Radioresistant SKOV-3 Tumors in Nude Mice  Stig Palm, Ph.D., Tom Bäck, Ingela Claesson, Anna.
High-Dose-Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes  Tania Kaprealian, M.D., Vivian Weinberg, Ph.D.,
Massive: Hemorrhagic Adrenal Pseudocyst
Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD 
Daniel S. Winchester, MD, Thomas L. Hocker, MD, Randall K. Roenigk, MD 
Treatment of Pathologic Fractures
Whitney A. High, MD, MEng, Reed A
Nivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non–Small Cell Lung Cancer  Hiromi Furuta, MD, PhD, Tatsuya Yoshida, MD, PhD,
Radiation resistance and stem-like cells in brain tumors
Volume 103, Issue 9, Pages (November 2012)
Volume 110, Issue 4, Pages (February 2016)
The Origin of Short Transcriptional Pauses
Effects of cancer treatment during pregnancy on fetal and child development  Tineke Vandenbroucke, MSc, Magali Verheecke, MD, Monica Fumagalli, MD, Christianne.
Electronic Updates for JTO Readers
Jeremy D. Wilson, Chad E. Bigelow, David J. Calkins, Thomas H. Foster 
Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei 
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.
Thoracic and abdominal aortic dimension in 70-year-old men and women – A population-based whole-body magnetic resonance imaging (MRI) study  Anders Wanhainen,
Michael J. Rosenbluth, Wilbur A. Lam, Daniel A. Fletcher 
A Model for the Transient Subdiffusive Behavior of Particles in Mucus
Not What She Had in Mind The American Journal of Medicine
Iris Metastasis from Small-Cell Lung Cancer
Treatment of Colorectal Cancer
Volume 83, Issue 5, Pages (November 2002)
Xinggui Gu, Ben Zhong Tang  Chem 
A New Angle on Microscopic Suspension Feeders near Boundaries
Presentation transcript:

Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab′)2  Jörgen Elgqvist, Ph.D., Håkan Andersson, M.D., Ph.D., Peter Bernhardt, Ph.D., Tom Bäck, Ingela Claesson, Ragnar Hultborn, M.D., Ph.D., Holger Jensen, Ph.D., Bengt R. Johansson, M.D., Ph.D., Sture Lindegren, Ph.D., Marita Olsson, Ph.D., Stig Palm, Ph.D., Elisabet Warnhammar, Lars Jacobsson, Ph.D.  International Journal of Radiation Oncology • Biology • Physics  Volume 66, Issue 4, Pages 1228-1237 (November 2006) DOI: 10.1016/j.ijrobp.2006.07.003 Copyright © 2006 Elsevier Inc. Terms and Conditions

Fig. 1 Scanning electron microscopy images illustrating tumors on the peritoneum in mice 4 weeks after intraperitoneal injection of OVCAR-3 cells. The specimens shown were taken from the upper left quadrant of the abdominal wall. Images like these were used to determine the size of the tumors, as well as the numbers of tumors of each size at the time of treatment. Panels (A), (B), and (C) show images of tumors with dimensions similar to those considered in the radiation dosimetry, i.e., rtumor equal to ∼30, ∼45, and ∼95 μm. Panel (D) shows an image where a typical distribution of tumor sizes is present. International Journal of Radiation Oncology • Biology • Physics 2006 66, 1228-1237DOI: (10.1016/j.ijrobp.2006.07.003) Copyright © 2006 Elsevier Inc. Terms and Conditions

Fig. 2 Specific energy to tumor cell nuclei as a function of distance from the tumor center for 3 tumor sizes (rtumor = 30, 45, and 95 μm). The 95 μm tumor represents the largest tumor found at the time of treatment. The specific energies are shown for the 4 activity levels used (25, 50, 100, and 200 kBq) as well as for the 4 irradiation geometries considered: activity homogeneously distributed at the antigenic sites throughout the whole tumor (▴), activity homogeneously distributed only at the antigenic sites within the assumed maximum diffusion depth (30 μm) (×), activity distributed only at those antigenic sites defining the surface of the tumor (), and activity homogeneously distributed in the abdominal fluid surrounding the tumor (▵). For each tumor size, the core (C) and shells (S) are indicated by the vertically dashed lines (- - -). The vertical lines farthest to the right and left for each tumor size represent the surface and the center of the tumor, respectively. The vertical solid line (—) in the 95-μm tumor diagrams represents the maximum path length of the α-particles when emitted from the surface of the tumor. The polynomial fits are indicated by the dotted lines (· · ·). International Journal of Radiation Oncology • Biology • Physics 2006 66, 1228-1237DOI: (10.1016/j.ijrobp.2006.07.003) Copyright © 2006 Elsevier Inc. Terms and Conditions